SCHEMBL1663957

SCHEMBL1663957

CC(C)=CCNc1ccc(-n2ncc3cc(NC(=O)c4ccc(N5CCOCC5)cc4)ccc32)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
KDM4E B2RXH2 1/20 0.55
HPGD P15428 1/20 0.55
ATM Q13315 1/20 0.53
TP53 P04637 3/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
PKM P14618 2/20 0.50
MAPK1 P28482 2/20 0.50
LMNA P02545 2/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
MAPK8 P45983 3/20 0.48
MAPK10 P53779 3/20 0.48
MAPK13 O15264 2/20 0.48
MAPK12 P53778 2/20 0.48
MAPK11 Q15759 2/20 0.48
MAPK14 Q16539 2/20 0.48
ALDH1A1 P00352 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664796 0.91 MAOB (0.45) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL8769687 0.88 MAPT (0.54) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL1664913 0.88 MAPT (0.59) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL8770017 0.88 MAPT (0.56) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL8771404 0.87 MAPT (0.67) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL1665410 0.87 MAPT (0.52) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL1664427 0.86 ALDH1A1 (0.52) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL17072301 0.86 MAPT (0.56) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL13974299 0.84 MAPT (0.49) MAPTSMN1; SMN2KDM4EHPGDATM
SCHEMBL1664425 0.84 LMNA (0.56) MAPTSMN1; SMN2KDM4EHPGDATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed